{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T11:14:04Z","timestamp":1770549244859,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11096-023-01584-y","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T12:02:36Z","timestamp":1684497756000},"page":"1317-1325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Shichun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghan","family":"Huanglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1796-6866","authenticated-orcid":false,"given":"Pan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"issue":"55","key":"1584_CR1","first-page":"5","volume":"4","author":"A Vinekar","year":"2022","unstructured":"Vinekar A, Sinha S, Mohan A, et al. Role of birth order in the development of retinopathy of prematurity in multiple gestation: a study of 1040 Asian Indian premature infants. SN Compr Clin Med. 2022;4(55):5\u20137.","journal-title":"SN Compr Clin Med"},{"issue":"4","key":"1584_CR2","first-page":"249","volume":"35","author":"M Du","year":"2020","unstructured":"Du M, Chen T, Yi Su, et al. Research progress on the risk factors of retinopathy of prematurity. Eye Sci. 2020;35(4):249\u201354.","journal-title":"Eye Sci."},{"issue":"7","key":"1584_CR3","first-page":"4201","volume":"63","author":"YG Justiniano-Becerra","year":"2022","unstructured":"Justiniano-Becerra YG, Ramirez-Solis F, Aguilar-Morales K, et al. Retinopathy of prematurity: 5 years and 715 patients, an epidemiological analysis. Invest Ophthalmol Vis Sci. 2022;63(7):4201\u2013F0261.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1584_CR4","first-page":"CD009734","volume":"1","author":"MJ Sankar","year":"2018","unstructured":"Sankar MJ, Sankar J, Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2018;1(1):CD009734.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"1584_CR5","first-page":"546","volume":"38","author":"E Jin","year":"2022","unstructured":"Jin E, Yin H, Wang Z, et al. Comparison of visual function and fundus structure outcomes in long-term follow-up of retinopathy of prematurity undergoing anti-vascular endothelia growth factor agents and laser treatment. Chin J Ocul Fundus Dis. 2022;38(7):546\u201350.","journal-title":"Chin J Ocul Fundus Dis"},{"issue":"2","key":"1584_CR6","first-page":"285","volume":"21","author":"X Qi","year":"2021","unstructured":"Qi X, Chao Z, Xiao J, et al. Anti-VEGF and laser therapy for type 1 retinopathy of prematurity: a Meta analysis. Int Eye Sci. 2021;21(2):285\u201390.","journal-title":"Int Eye Sci"},{"issue":"4","key":"1584_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/ciia.2006.1.4.451","volume":"1","author":"TE Kenneth","year":"2006","unstructured":"Kenneth TE, Kertes PJ. Ranibizumab in neovascular age-related macular degeneration. Clin Interv Aging. 2006;1(4):451\u201366.","journal-title":"Clin Interv Aging"},{"issue":"9","key":"1584_CR8","first-page":"2311","volume":"22","author":"X Lu","year":"2015","unstructured":"Lu X, Sun X. Profile of conbercept in the treatment of neovascular age-related macular degeneration. Drug Des Devel Ther. 2015;22(9):2311\u201320.","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"1584_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/jama.2022.9163","volume":"328","author":"RF Soll","year":"2022","unstructured":"Soll RF. Treatment of retinopathy of prematurity: moving forward with uncertainty. JAMA. 2022;328(4):332\u20133.","journal-title":"JAMA"},{"issue":"8","key":"1584_CR10","first-page":"1361","volume":"22","author":"X Chen","year":"2022","unstructured":"Chen X, Lu H, Wang T. Progress of the application of conbercept in ocular neovascular diseases. IES. 2022;22(8):1361\u20134.","journal-title":"IES"},{"key":"1584_CR11","unstructured":"Pediatric Retinology Group of Ophthalmology Professional Committee of Cross-Strait Medical and Health Exchange Association, Fundus Disease Group of Chinese Medical Association Ophthalmology Branch. Expert consensus on intravitreal injection of anti-vascular endothelial growth factor drugs for retinopathy of prematurity. Chin J Ocular Fundus Dis. 2021;37(11):836\u201340."},{"issue":"3","key":"1584_CR12","first-page":"487","volume":"21","author":"R Cao","year":"2021","unstructured":"Cao R, Li Y, Liu W, et al. Meta-analysis of comparison of IVB and IVR used for retinopathy of prematurity. IES. 2021;21(3):487\u201392.","journal-title":"IES"},{"issue":"12","key":"1584_CR13","first-page":"2242","volume":"17","author":"R Shi","year":"2017","unstructured":"Shi R, Yang L, Qi Y, et al. Comparison of conbercept with ranbizumab for the treatment efficiency of macular edema: a meta-analysis. IES. 2017;17(12):2242\u20137.","journal-title":"IES"},{"issue":"9","key":"1584_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"1584_CR15","first-page":"722","volume":"25","author":"F Ai","year":"2021","unstructured":"Ai F, Hu K, Shi J, et al. Quality assessment of cohort studies literature on Chinese smoking by using Newcastle-Ottawa-Scale. Chin J Disease Cont Prevent. 2021;25(6):722\u20139.","journal-title":"Chin J Disease Cont Prevent"},{"issue":"1","key":"1584_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials"},{"issue":"5","key":"1584_CR17","first-page":"866","volume":"21","author":"M Li","year":"2021","unstructured":"Li M, Wang L, Zhang Z, et al. Comparison of the effectiveness of conbercept versus rRanibizumab in the treatment of type 1 retinopathy of prematurity. IES. 2021;21(5):866\u201371.","journal-title":"IES"},{"issue":"8","key":"1584_CR18","doi-asserted-by":"publisher","first-page":"e1004","DOI":"10.1111\/aos.14460","volume":"98","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Zhu X, Linghu D, et al. Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity. Acta Ophthalmol. 2020;98(8):e1004\u20138.","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"1584_CR19","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1097\/IAE.0000000000001763","volume":"38","author":"E Jin","year":"2018","unstructured":"Jin E, Yin H, Li X, et al. Short-term outcomes after intravitreal injections of conbercept verus ranibizumab for the treatment of retinopathy of prematurity. Retina. 2018;38(8):1595\u2013604.","journal-title":"Retina"},{"key":"1584_CR20","unstructured":"Zheng B. Anti-vascular endothelial growth factor in the treatment of retinopathy of prematurity. J Fujian Med Univ. 2020:1\u201318."},{"issue":"11","key":"1584_CR21","first-page":"858","volume":"23","author":"Z Wang","year":"2021","unstructured":"Wang Z, Li Q, Yang X, et al. Comparison of the treatment outcomes for retinopathy of prematurity with an intravitreal injection of conbercept or ranibizumab. Chin J Optometry Ophthalmol Visual Sci. 2021;23(11):858\u201363.","journal-title":"Chin J Optometry Ophthalmol Visual Sci"},{"key":"1584_CR22","unstructured":"Yang D. Epidemiological study of retinopathy of prematurity in dalian and short term efficacy of Anti-VEGF therapy. J Dalian Med Univ. 2019:1\u201334."},{"issue":"7","key":"1584_CR23","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/bjophthalmol-2020-318026","volume":"106","author":"Z Wu","year":"2022","unstructured":"Wu Z, Zhao J, Lam W, et al. Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomised controlled trial. Br J Ophthalmol. 2022;106(7):975\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"21","key":"1584_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020222","volume":"99","author":"W Liu","year":"2020","unstructured":"Liu W, Li Y, Cao R, et al. A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion. Medicine (Baltimore). 2020;99(21): e20222.","journal-title":"Medicine (Baltimore)"},{"issue":"04","key":"1584_CR25","first-page":"826","volume":"40","author":"F Bai","year":"2020","unstructured":"Bai F, Ma X, Yan Y, et al. Comparison of the efficacy of ranibizumab and conbercept in the treatment of age-related macular degeneration. Chin J Gerontol. 2020;40(04):826\u20138.","journal-title":"Chin J Gerontol"},{"issue":"2","key":"1584_CR26","first-page":"458","volume":"45","author":"J Liu","year":"2020","unstructured":"Liu J, Gong J. Effects of ranibizumab and compaqip on BCVA, PLT and CMT in branch vein occlusion combined with macular edema. J Guangxi Univ(Natural Science). 2020;45(2):458\u201363.","journal-title":"J Guangxi Univ(Natural Science)"},{"issue":"1","key":"1584_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11095-008-9718-9","volume":"26","author":"M Zhang","year":"2009","unstructured":"Zhang M, Yu D, Yang C, et al. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization. Pharm Res. 2009;26(1):204\u201310.","journal-title":"Pharm Res"},{"issue":"3","key":"1584_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/CCM.0000000000002885","volume":"46","author":"RJ Stephens","year":"2018","unstructured":"Stephens RJ, Dettmer MR, Roberts BW, et al. Practice patterns and outcomes associated with early sedation depth in mechanically ventilated patients: a systematic review and meta-analysis. Crit Care Med. 2018;46(3):471\u20139.","journal-title":"Crit Care Med"},{"issue":"7","key":"1584_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002595","volume":"15","author":"N Alipanah","year":"2018","unstructured":"Alipanah N, Jarlsberg L, Miller C, et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7): e1002595.","journal-title":"PLoS Med"},{"issue":"8","key":"1584_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/medicina55080476","volume":"55","author":"D Su\u00e1rez-Iglesias","year":"2019","unstructured":"Su\u00e1rez-Iglesias D, Miller KJ, Seijo-Mart\u00ednez M, et al. Benefits of Pilates in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Medicina. 2019;55(8):47.","journal-title":"Medicina"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-023-01584-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T20:07:04Z","timestamp":1701115624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-023-01584-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1584"],"URL":"https:\/\/doi.org\/10.1007\/s11096-023-01584-y","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}